Skip to main content
. 2002 Feb 1;86(3):336–341. doi: 10.1038/sj.bjc.6600063

Figure 3.

Figure 3

Percentage of peripheral blood CD3−CD56+ CD69+ activated NK cells (y axis) among gated lymphocytes in tested patients (n=9), pre-treatment and post-treatment (x-axis). Patients with partial response (PR) are highlighted.